Grace Therapeutics, Inc. Increase (Decrease) in Deferred Charges
Grace Therapeutics, Inc. (GRCE) reported Increase (Decrease) in Deferred Charges of $19.00 thousand for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2020-08-13
- Grace Therapeutics, Inc. increase (decrease) in deferred charges for the quarter ending 2020-06-30 was $19.00K.
- Grace Therapeutics, Inc. increase (decrease) in deferred charges for the quarter ending 2020-03-31 was -$7.00K, a 105.22% decline year-over-year.
- Grace Therapeutics, Inc. increase (decrease) in deferred charges for the quarter ending 2019-03-31 was $134.00K.
| Period end | Increase (Decrease) in Deferred Charges 3 month | Increase (Decrease) in Deferred Charges 6 month |
|---|---|---|
| 2020-06-30 | $19.00K 10-Q · filed 2020-08-13 | $12.00K derived: sum of 2 quarters · filed 2020-08-13 |
| 2020-03-31 | -$7.00K 10-K · filed 2020-06-29 | |
| 2019-03-31 | $134.00K 10-K · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |